Lakefront Biotherapeutics NV has repurchased 77,667 of its own shares between June 15 and June 19, 2026, as part of the share repurchase program announced on June 9, 2026. The shares were bought on the Euronext market at an average price of €24.6586, for a total consideration of €1,915,162.13. Following these transactions, Lakefront holds 116,204 of its own ordinary shares as of market close on June 19, 2026.
LAKEFRONT BIOTHERAPEUTICS NV Company repurchased 77,667 shares under buyback program, signaling confidence and returning capital to shareholders.